2. Signaling Pathways
  3. Others
  4. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Related Products (2203):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-133967
    (25R)-26-Hydroxycholest-4-en-3-one
    		Control
    (25R)-26-Hydroxycholest-4-en-3-one is an oxysterol.
    (25R)-26-Hydroxycholest-4-en-3-one
  • HY-Z4696
    Dabigatran impurity 5
    Dabigatran impurity 5 is an impurity of Dabigatran (HY-10163).
    Dabigatran impurity 5
  • HY-Z0668
    6-(4-Hydroxyphenoxy)hexyl acetate
    6-(4-Hydroxyphenoxy)hexyl acetate is a drug impurity.
    6-(4-Hydroxyphenoxy)hexyl acetate
  • HY-W587540
    Descladinose 6-N-desmethyl azithromycin
    Descladinose 6-N-Desmethyl Azithromycin is a teramycin impurity.
    Descladinose 6-N-desmethyl azithromycin
  • HY-Z0675
    (Z)-3-phenyl-2-(propylimino)thiazolidin-4-one
    (Z)-3-phenyl-2-(propylimino)thiazolidin-4-one is a drug impurity.
    (Z)-3-phenyl-2-(propylimino)thiazolidin-4-one
  • HY-Z0138
    Nintedanib impurity 41
    Nintedanib impurity 41 is an impurity of Nintedanib (HY-50904).
    Nintedanib impurity 41
  • HY-W722043
    MFZ 2-13
    MFZ 2-13 (O-456) is an N-demethylated intermediate and N-nor-analogue of MFD 2-12. MFZ 2-13 inhibits dopamine uptake through the human dopamine receptor with an IC50 of 1.4 nM.
    MFZ 2-13
  • HY-W837678
    Terephthalic acid impurity 1
    Terephthalic acid impurity 1 is an impurity of Terephthalic acid (HY-W010098)
    Terephthalic acid impurity 1
  • HY-W700710
    (Rac)-7-Methoxy propranolol
    		Control
    (Rac)-7-Methoxy propranolol is a synthetic intermediate useful for pharmaceutical synthesis.
    (Rac)-7-Methoxy propranolol
  • HY-W025723A
    N-Carbobenzoxy-D-homoserine
    N-Carbobenzoxy-D-homoserine (N-(Benzyloxycarbonyl)-D-homoserine) is D-homoserine with N-Carbobenzoxy protecting group, which can be used to synthesize Antibody-Drug Conjugates (ADCs).
    N-Carbobenzoxy-D-homoserine
  • HY-134518
    Erythromycin oxime
    Erythromycin oxime is an intermediate of Azithromycin (HY-17506). Azithromycin is a macrolide antibiotic useful for the treatment of a number of bacterial infections.
    Erythromycin oxime
  • HY-Z4764
    Edoxaban impurity 62
    Edoxaban Impurity 62 is an impurity of Edoxaban (HY-10264).
    Edoxaban impurity 62
  • HY-78495
    Ticagrelor impurity 16
    		99.51%
    Ticagrelor impurity 16 is an impurity of Ticagrelor (HY-10064).
    Ticagrelor impurity 16
  • HY-Z16581
    Androstenediol impurity 1
    Androstenediol impurity 1 is a drug impurity.
    Androstenediol impurity 1
  • HY-W034154
    Dihydridotetrakis(triphenylphosphine)ruthenium(II)
    Dihydridotetrakis(triphenylphosphine)ruthenium(II) (Tetrakis(triphenylphosphine)ruthenium dihydride) is a catalyst with good catalytic activity. Dihydridotetrakis(triphenylphosphine)ruthenium(II) can be used in organic synthesis reactions, especially in hydrogenation and dehydrogenation reactions. Dihydridotetrakis(triphenylphosphine)ruthenium(II) has received extensive attention in the study of metal catalysts, and its high efficiency makes it an ideal research object.
    Dihydridotetrakis(triphenylphosphine)ruthenium(II)
  • HY-Z0710
    tert-Butyl 2-(4,5-dibromo-1H-imidazol-2-yl)pyrrolidine-1-carboxylate
    tert-Butyl 2-(4,5-dibromo-1H-imidazol-2-yl)pyrrolidine-1-carboxylate is a drug impurity.
    tert-Butyl 2-(4,5-dibromo-1H-imidazol-2-yl)pyrrolidine-1-carboxylate
  • HY-Z3345
    Ibrutinib impurity 14
    Ibrutinib Impurity 14 is an impurity of Ibrutinib (HY-10997).
    Ibrutinib impurity 14
  • HY-169878
    CNJ-294
    CNJ-294 is an intermediate in the synthesis of Capmatinib (HY-13404) and a metabolite of Capmatinib (HY-13404).
    CNJ-294
  • HY-W048402
    Neratinib impurity 11
    Neratinib impurity 11 is an impurity of Neratinib (HY-32721).
    Neratinib impurity 11
  • HY-118436
    3-Methyl-2-quinoxalinone
    		99.62%
    3-Methyl-2-quinoxalinone is a synthetic intermediate, and can be used for pharmaceutical synthesis.
    3-Methyl-2-quinoxalinone